Volastra Therapeutics

#DYK that 60% to 80% of all cancers are chromosomally unstable? At Volastra, we are advancing two clinical-stage #KIF18A inhibitors, #sovilnesib and VLS-1488, designed to disrupt #cancer cell division and deliver enhanced efficacy across a broader patient population.    Read as our CEO, Charles Hugh-Jones, discusses our story and how we are leveraging KIF18A inhibition to exploit #chromosomal_instability (CIN) in cancer cells in Life Science Leader’s latest ‘Companies to Watch’ feature by Ben Comer.    Access the full article here: https://bit.ly/3VZLyLB 

Join Volastra Therapeutics! Volastra Therapeutics is seeking a Research Associate II/Senior Research Associate in Tumor Immunology to join our NYC team. We are a clinical-stage oncology biotech focused on exploiting chromosomal instability (CIN) to combat cancer, backed by top venture firms and strategic partnerships. You'll collaborate with our scientific team to validate novel targets and advance key drug development programs, involving cell culture, gene expression manipulation, biochemical assays, and data analysis. Ready to make a difference? Apply here: https://lnkd.in/gVUEd-ru #Hiring #Oncology #ResearchAssociate #BiotechJobs #VolastraTherapeutics #CancerResearch #JoinOurTeam #NYCJobs

We are on the ground at #ASCO24 in Chicago! Connect with us to learn more about one of our two #clinicaltrials evaluating our internally discovered clinical-stage #KIF18A inhibitor, VLS-1488, in patients with advanced #cancers. View the abstract here: https://lnkd.in/e4nSvM8B   American Society of Clinical Oncology (ASCO)

Heading to #ASCO24 next week? Join us as we provide an overview of our Phase I/II #clinicaltrial of VLS-1488, one of our clinical-stage #KIF18A inhibitors for patients with advanced #cancers. See more details below and view our full abstract here: https://lnkd.in/e4nSvM8B American Society of Clinical Oncology (ASCO)

Cheers to five years of dedication from our fantastic Volastra team in the fight against #cancer. As we look back on our team’s accomplishments and milestones, we’re proud of our growth and grateful for our collective commitment to advancing life-changing therapies for patients.

We're expanding our team with two key roles: 1️⃣ Director/Senior Director, Biostatistics/Biometrics: Lead our Biostatistics function in the development of our clinical trial programs. Bring your extensive experience in oncology clinical trials and statistical analysis to drive successful outcomes. Learn more and apply here: https://lnkd.in/eH-5FrhE 2️⃣ Senior Scientist/Associate Director, Bioinformatics: Join our dynamic research team and contribute to the development of our preclinical and clinical stage assets. Apply your expertise in cancer biology, computational biology, and multi-modal data analysis to drive impactful discoveries. Learn more and apply here: https://lnkd.in/eQ6-Uwta At Volastra, you'll join a passionate team dedicated to advancing therapies for cancer patients. Visit our website to learn more about our mission and culture: www.volastratx.com. #VolastraTherapeutics #Biostatistics #Bioinformatics #OncologyResearch #ClinicalTrials #NowHiring #NYCJobs

Join us at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting next month! We look forward to sharing details from our ongoing Phase 1 trial investigating VLS-1488, one of our two clinical-stage #KIF18A inhibitors, for the treatment of advanced #cancers. #ASCO24

Our Head of Research & Development and Chief Medical Officer, Scott Drutman MD PhD, sat down with Madeleine Armstrong of ApexOnco to talk more about how we’re leveraging #KIF18A inhibition to disrupt #cancer cell division and create more effective therapeutics for cancer patients with our clinical-stage KIF18A inhibitors, VLS-1488 and sovilnesib. Check out the article: https://lnkd.in/ek9GDsYs

We're expanding our team with two key roles: 1️⃣ Director/Senior Director, Biostatistics/Biometrics: Lead our Biostatistics function in the development of our clinical trial programs. Bring your extensive experience in oncology clinical trials and statistical analysis to drive successful outcomes. Learn more and apply here: https://lnkd.in/eH-5FrhE 2️⃣ Senior Scientist/Associate Director, Bioinformatics: Join our dynamic research team and contribute to the development of our preclinical and clinical stage assets. Apply your expertise in cancer biology, computational biology, and multi-modal data analysis to drive impactful discoveries. Learn more and apply here: https://lnkd.in/eQ6-Uwta At Volastra, you'll join a passionate team dedicated to advancing therapies for cancer patients. Visit our website to learn more about our mission and culture: www.volastratx.com. #VolastraTherapeutics #Biostatistics #Bioinformatics #OncologyResearch #ClinicalTrials #NowHiring #NYCJobs

We are proud to announce that we dosed the first #ovariancancer patient in a Phase 1b #clinicaltrial for our #KIF18A inhibitor, #sovilnesib, and celebrate this major milestone in our fight against #cancer. Learn more: https://lnkd.in/eT-gtmEQ